BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 15257980)

  • 1. Statement on intractable pain treatment acts.
    American Alliance of Cancer Pain Initiatives
    J Pain Palliat Care Pharmacother; 2004; 18(2):93-8. PubMed ID: 15257980
    [No Abstract]   [Full Text] [Related]  

  • 2. Aspects of the problems in treating chronic pain: Florida pain management guidelines.
    Skinner M
    J Fla Med Assoc; 1997 Feb; 84(2):85-6. PubMed ID: 9066229
    [No Abstract]   [Full Text] [Related]  

  • 3. The intractable pain treatment act of Texas.
    Hill CS
    Tex Med; 1992 Feb; 88(2):70-2. PubMed ID: 1348377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pain: the doctor's dilemma.
    Phelps GL
    Tenn Med; 2011 Apr; 104(4):7-8. PubMed ID: 21560903
    [No Abstract]   [Full Text] [Related]  

  • 5. Can we manage pain?
    Cornell DH
    N J Med; 1997 May; 94(5):41-4. PubMed ID: 9164103
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pathophysiology and treatments of cancer pain with treatments of cancer pain refractory to opioids].
    Shimoyama N; Shimoyama M
    Masui; 2008 Nov; 57 Suppl():S170-9. PubMed ID: 22462175
    [No Abstract]   [Full Text] [Related]  

  • 7. Re: Nov/Dec 2004 article "New guidance issued for opioid pain medication" .
    CA Cancer J Clin; 2005; 55(1):1-2. PubMed ID: 15768485
    [No Abstract]   [Full Text] [Related]  

  • 8. What is being done to address the new drug epidemic?
    Dekker AH
    J Am Osteopath Assoc; 2007 Sep; 107(9 Suppl 5):ES21-6. PubMed ID: 17908827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The painkiller prescription: protect use, prevent abuse.
    Sullivan LW
    Med Econ; 2001 Sep; 78(17):18-9. PubMed ID: 11573391
    [No Abstract]   [Full Text] [Related]  

  • 10. Helping patients. Protecting yourself.
    Guglielmo WJ
    Med Econ; 2004 Jun; 81(12):69-70, 72-4, 76. PubMed ID: 15279400
    [No Abstract]   [Full Text] [Related]  

  • 11. The potent perils of a miracle drug.
    Roche T
    Time; 2001 Jan; 157(1):47. PubMed ID: 11194416
    [No Abstract]   [Full Text] [Related]  

  • 12. Relationship among cultural, educational, and regulatory agency influences on optimum cancer pain treatment.
    Hill CS
    J Pain Symptom Manage; 1990 Feb; 5(1 Suppl):S37-45. PubMed ID: 1969891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. State cancer pain initiatives.
    Dahl JL
    NIDA Res Monogr; 1993; 131():260-5. PubMed ID: 8413539
    [No Abstract]   [Full Text] [Related]  

  • 14. Guidelines for breakthrough pain dosing.
    Davis MP
    Am J Hosp Palliat Care; 2003; 20(5):334. PubMed ID: 14529035
    [No Abstract]   [Full Text] [Related]  

  • 15. [Does a doctor care about a cancer patient's pain?].
    Paija O
    Duodecim; 2004; 120(6):665-71. PubMed ID: 15119227
    [No Abstract]   [Full Text] [Related]  

  • 16. Easing cancer pain through treatment options.
    Ogle KS
    Mich Health Hosp; 1999; 35(2):14-6. PubMed ID: 10350803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pain treatment, drug diversion, and the casualties of war.
    Burgess F
    Pain Med; 2006; 7(6):474-5. PubMed ID: 17112360
    [No Abstract]   [Full Text] [Related]  

  • 18. How to reduce fears of legal/regulatory scrutiny in managing pain in cancer patients.
    Dahl JL
    J Support Oncol; 2005; 3(5):384-8. PubMed ID: 16218263
    [No Abstract]   [Full Text] [Related]  

  • 19. Perspectives. Grassroots state initiatives wage war on cancer pain.
    Faulkner Grays Med Health; 1995 Aug; 49(32):suppl 1-4. PubMed ID: 10146188
    [No Abstract]   [Full Text] [Related]  

  • 20. Commentary: the potential for unintended consequences from public policy shifts in the treatment of pain.
    Haddox JD; Aronoff GM
    J Law Med Ethics; 1998; 26(4):350-2, 263. PubMed ID: 11066894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.